glp 1 agonist drugs America's Poison Centers GLP-1 and Dual GIP/GLP-1 Agonists
Description
Not for human or veterinary use
GLP-1 drugs such as semaglutide are reshaping treatment of obesity, diabetes and cardiovascular disease with broader physiological effects now emerging.
In conjunction with all the effects, GLP-1 RAs have been found to lower weight and aid in weight management.
DPP-4 inhibitors were introduced for the treatment of type 2 diabetes in 2006
Mounjaro and Ozempic both help control blood sugar and promote weight loss in people with diabetes
